Incyte INCY announced new 24-week interim data from the STOP-HS program on pipeline candidate, povorcitinib (INCB54707), in ...

Incyte Announces New 24-Week Phase 3 Data from the STOP-HS Clinical Trial Program of Povorcitinib in Hidradenitis Suppurativa ...

Sanofi’s brivekimig met the primary endpoint in a Phase IIa trial in patients naïve to biologics with moderate-to-severe ...

Incyte (INCY) announced new 24-week interim data evaluating the safety and efficacy of povorcitinib, an oral small-molecule highly-selective JAK1 ...

Persistent tooth infection may cause ear and head pain because of the connection between your teeth and the trigeminal nerve.

Thousands of much-needed dental appointments have been made available for people in Birmingham and Solihull who are desperate ...

Andrew Oakes told Newsweek he wanted to die after the diagnosis because it was like a dirty secret and people called him reckless.

EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study In phase 2a study, brivekimig led to clinically meaningful improvements in primary and key secondary ...

AbstractCanine demodicosis is a skin disease caused by the overgrowth of Demodex mites viz. Demodex canis, D. injai and D. cornei in dogs. While these mites normally live harmlessly on dog’s skin, ...

Some of Sanofi’s most high-profile readouts this year can’t have made for easy reading at the French pharma’s Paris ...

A Hartlepool vets practice has had 10 seals brought to the surgery, either dead, or needing to be put to sleep ...

In a recent study, Dr. Claudine Abegg and her colleagues analyzed the remains of a mummified cranium housed in the ...